Selling Your Veterinary Practice or Animal Hospital
A confidential, advisor-run process built to create competitive tension among vetted consolidators and platforms — not a listing on a practice-sales board. Understand what your practice is worth, who is buying in 2026, and how a sell-side process protects your value and your team.
Inquiries are strictly confidential — no public listing of your firm.
A listing is not a process
Search "veterinary practice for sale" and you will find listing marketplaces and practice-transition boards. Posting your hospital to a board — or taking the first unsolicited call from a consolidator — is not the same as running a sell-side process, and the difference shows up in your final number.
5x – 8x adjusted EBITDA
rising to 12x–15x for platform-eligible, multi-DVM hospitals with $1M+ EBITDA; solo, owner-dependent practices are often capped nearer 3.5x–6x. Doctor count and production depth explain most of the spread
Who is buying veterinary practices in 2026
The buyer universe for veterinary practices has consolidated dramatically — PE-backed and corporate ownership grew from roughly 8% of the market in 2011 to about 50% by 2025. After a softer 2025, capital is rebounding, and multi-DVM hospitals with real associate depth are being bid up.
A note on veterinary practice ownership rules
Many states restrict ownership of a veterinary practice to licensed veterinarians under "corporate practice of veterinary medicine" (CPVM) doctrines. Corporate consolidators and PE platforms commonly acquire in these states through a management services organization (MSO): a "friendly PC" owned by a licensed veterinarian retains clinical control and patient records, while an MSO owns the non-clinical assets — facility, equipment, inventory, and administrative staff — and provides management services under a long-term agreement. Understanding whether your state requires this structure, and how it affects your entity, your real estate, and your post-close role, is part of positioning the deal correctly before you go to market.
Corporate consolidators
National corporate operators acquiring for scale, purchasing leverage, and referral density — Mars Veterinary Health (VCA, Banfield, BluePearl), Mission Pet Health (the merged Southern Veterinary Partners + Mission Veterinary Partners, now 840+ locations across 41 states), NVA (backed by JAB), Thrive Pet Healthcare, and PetVet Care Centers (KKR). Typically structured with holdbacks, equity rollover, and multi-year DVM employment agreements — not clean exits.
PE-backed platforms & regional roll-ups
Private-equity-sponsored buy-and-build platforms and emerging regional consolidators assembling a footprint before a larger recapitalization. They pay for platform-eligible hospitals ($1M+ EBITDA, multiple DVMs) and value defensible margins, clean add-backs, and documented KPIs. Financial-sponsor appetite is strengthening into 2026–2027 as LP demand for liquidity drives dealmaking.
Associate-vet succession
A single buyer, associate DVM, or partner group acquiring the practice for succession. Best fit for smaller, relationship-driven practices with a clear transition runway where the owner wants continuity of culture and staff over the top corporate multiple.
Capstone Partners tracked 18 pet-sector M&A transactions in year-to-date 2026 — more than double the 8 in the same period of 2025 — with Vet & Health the single largest segment (nine deals). Strategic-buyer activity climbed from 3 to 10 transactions year over year.
A clear signal that transactions delayed through 2025 are materializing and buyer appetite has rebounded — with veterinary hospitals leading the recovery. Well-prepared multi-DVM practices are meeting a market with renewed competitive tension.
How a sell-side process works, end to end
A structured process is what turns "I got a call from a consolidator" into "I ran a market and chose the best one." Each stage is designed to protect your confidentiality and your leverage.
- 013–5 weeks
Preparation & positioning
Normalize financials, recast owner compensation and personal add-backs, and build the confidential information memorandum that frames your DVM depth and recurring-revenue story.
- 021–2 weeks
Valuation & strategy
Establish a defensible value range and target the right buyer archetype — corporate consolidator, PE platform, or succession buyer.
- 034–6 weeks
Confidential buyer outreach
Approach a curated set of vetted buyers under NDA. No public listing, no exposure to clients, DVMs, or staff.
- 042–4 weeks
Offers & LOI
Drive competitive tension to a deadline, compare structures side by side — headline multiple versus rollover, holdback, and employment terms — and negotiate the letter of intent.
- 054–8 weeks
Diligence
Manage the buyer's quality-of-earnings, clinical, and real-estate review while keeping the deal on track and confidentiality intact.
- 062–4 weeks
Close & transition
Finalize terms, fund, and execute the DVM retention and transition plan that keeps doctors, staff, and clients in place.
Deal structures owners should understand
Very few veterinary deals are all-cash at close. Knowing the levers in advance is how you avoid leaving value — or protection — on the table.
Asset vs. equity sale
Whether the buyer purchases the practice's assets or the entity itself changes tax treatment and liability — a decision worth modeling before you go to market, especially where the real estate is held in a related entity.
Earnouts & holdbacks
Buyers increasingly tie a portion of price to post-close EBITDA or production. Common in platform deals; the targets and measurement period decide whether it is fair or a discount in disguise.
DVM employment & retention
Buyers price in your continued clinical involvement to retain clients and staff. The length, compensation, and non-compete terms of your post-close employment agreement are negotiable and material to your net outcome.
Rollover equity
Reinvesting part of your proceeds into the acquiring platform — a "second bite" if the platform grows and recapitalizes. Standard in PE and consolidator structures, and often the largest driver of total return.
What to fix before you go to market
The same levers buyers price are the ones you can move beforehand. Addressing them early is the highest-ROI work an owner can do before a sale.
Build associate-DVM depth
Buyers discount practices that revolve around the owner-veterinarian. Adding and retaining associate DVMs so the hospital runs — and produces — without you is the single biggest driver of a platform multiple.
Clean up the add-backs
Document owner compensation, personal expenses, and one-time costs so your adjusted EBITDA is defensible. Sloppy or aggressive add-backs get stripped out in quality-of-earnings and cost you multiple.
Strengthen margins and KPIs
Consistent EBITDA margins, healthy ACT/production per DVM, and documented KPIs signal operational quality and support the top of the range.
Lock in staff and lease continuity
Retention of key DVMs and technicians — and a clean, assignable real-estate lease — protects the client base and the multiple through transition.
Frequently asked questions
Through a confidential sell-side process: prepare and value the practice, recast the financials, approach vetted buyers under NDA, drive competitive offers, negotiate the LOI, and manage diligence to close. The goal is to run a market rather than accept a single consolidator's inbound offer.
Veterinary practices commonly sell for roughly 5x–8x adjusted EBITDA, with platform-eligible, multi-DVM hospitals ($1M+ EBITDA) reaching 12x–15x and solo, owner-dependent practices nearer 3.5x–6x. Doctor count, associate depth, and margin durability drive where you land. See what your practice is worth for a current estimate.
Corporate consolidators (Mars/VCA, Mission Pet Health, NVA, Thrive, PetVet Care Centers), PE-backed buy-and-build platforms and regional roll-ups, and individual or associate-DVM succession buyers. PE-backed and corporate ownership reached roughly half the market by 2025, and buyer appetite rebounded through 2026.
It depends on your state. Many states restrict practice ownership to licensed veterinarians under corporate-practice-of-veterinary-medicine rules, so corporate buyers acquire through a management services organization (MSO) paired with a veterinarian-owned "friendly PC." The right structure is part of preparing the deal.
A well-run sell-side process typically runs four to seven months from preparation to close, depending on practice size, diligence complexity, real-estate treatment, and the DVM transition plan.
Start a confidential valuation conversation
No public listing, no upfront fees. Understand what your veterinary practice is worth and what a real sell-side process could deliver. 100% success fee · $0 upfront · $1B+ closed.